ABBY CAYLOR: Open Payments
NPI 1669190260 · PUNXSUTAWNEY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,067 in 156 payments from 31 companies in 2025. Trend: 2023 $2,193 · 2024 $1,897 · 2025 $4,067
Food & beverage: $2,831Travel & lodging: $1,201Speaker / faculty: $35
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 6 | $1,396 |
| ABBVIE INC. | 43 | $618 |
| Teva Pharmaceuticals USA, Inc. | 28 | $330 |
| Biogen, Inc. | 8 | $244 |
| PFIZER INC. | 13 | $141 |
| TG Therapeutics, Inc. | 4 | $129 |
| MDD US Operations, LLC | 3 | $113 |
| UCB, Inc. | 4 | $107 |
| Celgene Corporation | 6 | $99 |
| ACADIA Pharmaceuticals Inc | 4 | $86 |
Products named: Vercise, QULIPTA, AUSTEDO XR, TYSABRI, BRIUMVI, NURTEC ODT, UBRELVY, ZEPOSIA.
Industry payments across PA — which companies pay providers there.
